U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
South Korea, US Discuss Warship Building Cooperation
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Australia Tightens Student Visa Rules, Targets Migration Cut by 2028
3 clinical-grade skincare creams you really shouldn’t buy online
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
FCC Approves Foreign Investment in $110B Paramount-Warner Bros. Deal
FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
White House Bars CNN, MS NOW and Politico Reporters
Trump Asks Supreme Court to Restore Third-Country Deportations
Taiwan Thanks US for Support Ahead of Trump-Xi Summit
Netanyahu Takes Aim at Mamdani as Israel Election Nears
Najib Razak Seeks Stay of 15-Year 1MDB Prison Sentence
Judge Orders Trump to Restore White House Access for CNN, MS NOW and Politico 



